Ansell Gloves CE Gloves Lab Gloves Cytostatics permeation chart 15 min Methotrexate 30 min Methotrexate Contact time 60 min Methotrexate Key to Protection level 25°C 37°C 43°C
Level 1 : Permeation detected above to 10 times below EN374-3 limit requirement
Level 2 : Permeation detected 10 to 100 times below EN374-3 limit requirement
Level 3 : Permeation detected 100 to 1.000 times below EN374-3 limit requirement
Level 4 : Permeation detected 1.000 to 10.000 times below EN374-3 limit requirement
Results obtained at room temperature. These results are ONLY and SOLELY valid or the glove
Level 5 : Permeation detected 10.000 to 100.000 times below EN374-3 limit requirement
tested. Any extrapolation to other materials,
Level 6 : > Permeation detected at least 100.000 times below EN374-3 limit requirement or
erroneous and NOT supported by Ansell.
Ansell Limited is a global leader in barrier protective products. With operations in the Americas, Europe and Asia, Ansell employs more than 11,000 people worldwide and holds leading positions in the natural latex and synthetic polymer glove and condom markets.
Ansell operates in three main business segments: Occupational Healthcare, supplying hand protection to the industrial market; Professional Healthcare, supplying surgical and examination gloves to healthcare professionals; and Consumer Healthcare, supplying condoms and consumer hand protection. Ansell UK Ltd Ansell Healthcare Europe N.V.
Regus Building, Blythe Valley Business Park
Riverside Business Park, Block J, Boulevard International 55 B-
Solihull West Midlands B90 8AG, United-Kingdom
Tel. +44 (0) 1564 711 802 - Fax +44 (0) 1564 711 344
Tel. +32 (0) 2 528 74 00 - Fax +32 (0) 2 528 74 01
http://www.ansell.eu - E-mail: [email protected]
Fax Customer Service +32 (0) 2 528 74 03 http://www.ansell.eu - E-mail: [email protected]
Ansell invests for your protection and information
In partnership with the Université Catholique de Louvain Brussels - Belgium
the existence of steadily ageing populations in both developed
numbers of those adopting unhealthy lifestyles. ACPP project goals:
• To contribute to better protection for healthcare personnel handling cytostatics• To present results corresponding to real life conditions or, better still, to worst case
scenarios (dynamic treatment & cytostatic concentration)
• To be innovative & bring very practical answers to our customers
Permeation: a very complex process Cytostatic characteristics characteristics Exposure Permeation parameters
Permeation depends on many parameters and therefore the results obtained cannot be ex-tended to any other material, brand or competitive product. The molecules tested are the following Analytical Concentra- Cytostatic Brand name (Detection (Quantification
Pharmacia & UpJohn LCMS/MS 100.0 mg/ml
Pharmacia & UpJohn HPLC-DAD 50.0 mg/ml
* LC-MS/MS: Liquid Chromatography Tandem Mass Spectrometry* HPLC -DAD: High Pressure Liquid Chromatography - Diode Array Detection
ANATOMY – PHYSIOLOGY Menstrual Cycle LAB Purpose:______________________________________________________________________________ __________________________________________________________ Observation Questions 1. Between days 25 and 12 (not 12 to 25) of the menstrual cycle, what happens to the amount of FSH produced by the body of an average human female? _______________________
PROTEINS: Structure, Function, and Genetics 53:683– 692 (2003) Automatic Annotation of Protein Function Based on Family Identification Federico Abascal * and Alfonso Valencia Protein Design Group, National Centre for Biotechnology, CNB-CSIC, Cantoblanco, Madrid, Spain ABSTRACT Although genomes are being se- accessed at http://www.pdg.cnb.uam.es/funcut.html. quenced at an im
Ansell invests for your protection and information
In partnership with the
The molecules tested are the following